West Paces Advisors’s West Pharmaceutical WST Stock Holding History

West Paces Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.18K	Buy	+20	New	+$6.12K	﹤0.01%	417
2025 Q2	–	Sell	-21	Closed	-$4.7K	–	568
2025 Q1	$4.7K	Sell	21 -1	-5%	-$276	﹤0.01%	388
2024 Q4	$7.21K	Hold	22	–	–	﹤0.01%	368
2024 Q3	$6.6K	Hold	22	–	–	﹤0.01%	375
2024 Q2	$7.25K	Hold	22	–	–	﹤0.01%	372
2024 Q1	$8.71K	Hold	22	–	–	﹤0.01%	372
2023 Q4	$7.75K	Hold	22	–	–	﹤0.01%	382
2023 Q3	$8.26K	Hold	22	–	–	﹤0.01%	362
2023 Q2	$8.41K	Hold	22	–	–	﹤0.01%	383
2023 Q1	$7.62K	Buy	22 +20	+1,000%	+$5.84K	﹤0.01%	389
2022 Q4	$471	Buy	+2	New	+$474	﹤0.01%	511
2022 Q3	–	Sell	-38	Closed	-$11.5K	–	586
2022 Q2	$11.5K	Hold	38	–	–	﹤0.01%	357
2022 Q1	$15.6K	Hold	38	–	–	﹤0.01%	336
2021 Q4	$17.8K	Buy	38 +3	+9%	+$1.29K	0.01%	324
2021 Q3	$14.9K	Hold	35	–	–	0.01%	322
2021 Q2	$12.6K	Buy	+35	New	+$11.6K	﹤0.01%	339

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

West Paces Advisors's WST Position: Q2 2026 in Review

West Paces Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 20 shares worth $7.18K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in WST as recently as Q1 2025.

West Paces Advisors first reported a position in WST in Q2 2021 and has held it in 16 quarters since. The position peaked at $17.8K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

West Paces Advisors held 20 shares of West Pharmaceutical worth $7.18K as of Q2 2026.
West Pharmaceutical was a new West Paces Advisors position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #417 holding.
West Paces Advisors first reported a position in West Pharmaceutical in Q2 2021 and has held it in 16 quarters since.
West Paces Advisors's West Pharmaceutical position peaked at $17.8K in Q4 2021.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.